feedback - Recensione dipendente - Sales Representative presso Viatris

4,0
29 nov 2020
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Small Pharma with big Pharma mentality

Svantaggi

Limited Branded products and no current pipeline

avatar
Risposta di Viatris
5y
Thanks for your feedback. Now that Mylan and Upjohn have combined to form Viatris, we have a global portfolio of more than 1,400 molecules across a broad range of major therapeutic areas, including best-in-class, iconic brand-name products, as well as global key brands, generics, including branded and complex generics, biosimilars and over-the-counter offerings. We are uniquely positioned to help meet the world’s evolving healthcare needs, and it’s rewarding to be part of a team that is able to make a difference!

Esplora altre recensioni su Viatris

5,0
25 feb 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great people and the having this kind of experience on your resume is a plus. You often get opportuinites to make impressions on higher management from other teams/divisions.

Svantaggi

There aren't too many that stick out which would lead me not to recommend this role.

1,0
3 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

•it pays, but not a serious company. •no new data in 5-10 years, Viatris is a Pfizer pet project went wrong.

Svantaggi

•New England respiratory was an unmitigated disaster. •Very little competent management , the company doesn’t seem interested in succeeding.

Vedi recensioni per: Utile|Valutazione|Data|Tutto